Delia D’Avola

3.5k total citations · 1 hit paper
60 papers, 2.1k citations indexed

About

Delia D’Avola is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Delia D’Avola has authored 60 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hepatology, 28 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in Delia D’Avola's work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Liver Disease Diagnosis and Treatment (18 papers) and Liver Disease and Transplantation (11 papers). Delia D’Avola is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Liver Disease Diagnosis and Treatment (18 papers) and Liver Disease and Transplantation (11 papers). Delia D’Avola collaborates with scholars based in Spain, United States and Italy. Delia D’Avola's co-authors include Bruno Sangro, Mercedes Iñarrairaegui, J.I. Herrero, José Ignacio Bilbao, Jorge Quiroga, Jesús Prìeto, Alberto Benito, Macarena Rodríguez‐Fraile, Fernando Pardo and Antonio Martínez-Cuesta and has published in prestigious journals such as Hepatology, Oncogene and Scientific Reports.

In The Last Decade

Delia D’Avola

58 papers receiving 2.0k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment

2023 77 citations Bruno Sangro, Delia D’Avola et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Delia D’Avola Spain	25	1.2k	726	489	407	396	60	2.1k
Xiaoping Chen China	29	1.2k 1.0×	554 0.8×	741 1.5×	564 1.4×	512 1.3×	111	2.2k
Matthew M. Yeh United States	28	921 0.8×	528 0.7×	1.1k 2.2×	850 2.1×	429 1.1×	83	2.4k
Kuansheng Ma China	24	1.5k 1.2×	930 1.3×	704 1.4×	395 1.0×	154 0.4×	97	2.0k
Nils Kinnman Sweden	19	809 0.7×	666 0.9×	405 0.8×	351 0.9×	277 0.7×	33	2.0k
Judith Stift Austria	27	917 0.8×	837 1.2×	319 0.7×	534 1.3×	262 0.7×	73	1.9k
Atsushi Nanashima Japan	26	1.1k 0.9×	618 0.9×	1.2k 2.4×	685 1.7×	444 1.1×	210	2.6k
Oleksiy Tsybrovskyy Austria	17	655 0.5×	613 0.8×	731 1.5×	838 2.1×	291 0.7×	37	1.8k
Juan Putra United States	17	578 0.5×	356 0.5×	403 0.8×	859 2.1×	308 0.8×	67	1.9k
Ryuichi Kita Japan	25	1.3k 1.1×	923 1.3×	370 0.8×	359 0.9×	238 0.6×	76	1.8k
Masahiro Ohira Japan	22	502 0.4×	358 0.5×	491 1.0×	572 1.4×	415 1.0×	185	2.0k

Countries citing papers authored by Delia D’Avola

Since Specialization

Citations

This map shows the geographic impact of Delia D’Avola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delia D’Avola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delia D’Avola more than expected).

Fields of papers citing papers by Delia D’Avola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Delia D’Avola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delia D’Avola. The network helps show where Delia D’Avola may publish in the future.

Co-authorship network of co-authors of Delia D’Avola

This figure shows the co-authorship network connecting the top 25 collaborators of Delia D’Avola. A scholar is included among the top collaborators of Delia D’Avola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Delia D’Avola. Delia D’Avola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Argemí, Josepmaria, et al.. (2025). Immune-Checkpoint Inhibitors for Biliary Tract Cancer: Who Benefits and What Is Next?. Cancers. 17(17). 2811–2811. 1 indexed citations

Morales, Xabier, Sergio Ortiz‐Espinosa, Borja Ruiz‐Fernández de Córdoba, et al.. (2022). Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood. Bioengineering & Translational Medicine. 7(3). e10331–e10331. 7 indexed citations

Craig, Amanda J., Teresa García‐Lezana, Marina Ruiz de Galarreta, et al.. (2021). Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma. PLoS Genetics. 17(6). e1009589–e1009589. 16 indexed citations

D’Avola, Delia, et al.. (2021). The importance of liver functional reserve in the non-surgical treatment of hepatocellular carcinoma. Journal of Hepatology. 76(5). 1185–1198. 51 indexed citations

Labgaa, Ismaïl, Johann von Felden, Amanda J. Craig, et al.. (2021). Experimental Models of Liquid Biopsy in Hepatocellular Carcinoma Reveal Clone‐Dependent Release of Circulating Tumor DNA. Hepatology Communications. 5(6). 1095–1105. 5 indexed citations

Felden, Johann von, Amanda J. Craig, Teresa García‐Lezana, et al.. (2020). Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma. Oncogene. 40(1). 140–151. 99 indexed citations

Casadei‐Gardini, Andrea, José Ignacio Bilbao, Macarena Rodríguez‐Fraile, et al.. (2020). The Pattern of Progression Defines Post-progression Survival in Patients with Hepatocellular Carcinoma Treated with SIRT. CardioVascular and Interventional Radiology. 43(8). 1165–1172. 8 indexed citations

Martins-Filho, Sebastião N., Venâncio Avancini Ferreira Alves, Alda Wakamatsu, et al.. (2019). A phenotypical map of disseminated hepatocellular carcinoma suggests clonal constraints in metastatic sites. Histopathology. 74(5). 718–730. 7 indexed citations

D’Avola, Delia, José Ignacio Bilbao, & Bruno Sangro. (2019). Hepatocellular Carcinoma: Essentials Interventional Radiologists Need to Know. CardioVascular and Interventional Radiology. 42(9). 1262–1270. 2 indexed citations

10.

D’Avola, Delia, Carlos Villacorta-Martín, Sebastião N. Martins-Filho, et al.. (2018). High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma. Scientific Reports. 8(1). 11570–11570. 62 indexed citations

11.

Herrero, Ignacio, Manuel de la Mata, Trinidad Serrano, et al.. (2016). Controlling Diabetes After Liver Transplantation. Transplantation. 100(10). e66–e73. 13 indexed citations

12.

Zabaleta, Aintzane, Delia D’Avola, Diana Llópiz, et al.. (2015). Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection. Molecular Therapy — Methods & Clinical Development. 2. 15006–15006. 16 indexed citations

13.

D’Avola, Delia, Marta Lasa, Mercedes Iñarrairaegui, et al.. (2015). P0235 : Protein N-terminal acetylation inhibition as a novel therapeutic target for hepatocellular carcinoma. Journal of Hepatology. 62. S395–S395. 1 indexed citations

14.

Silva, Nuno A., José Ignacio Bilbao, Mercedes Iñarrairaegui, et al.. (2013). Partial liver volume radioembolization induces hypertrophy in the spared hemiliver and no major signs of portal hypertension. HPB. 16(3). 243–249. 56 indexed citations

15.

Garza, Rocío García de la, Pablo Sarobe, Juana Merino, et al.. (2013). Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance. Liver Transplantation. 19(9). 937–944. 70 indexed citations

16.

Rodríguez–Lago, Iago, Delia D’Avola, Mercedes Iñarrairaegui, et al.. (2012). Rhabdomyolysis after Intentional Acetaminophen and Carbon Monoxide Poisoning. Journal of Gastroenterology and Hepatology Research. 1(6). 111–113.

17.

Herrero, J.I., Fernando Pardo, Delia D’Avola, et al.. (2011). Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation. Liver Transplantation. 17(4). 402–408. 78 indexed citations

18.

Vespasiani‐Gentilucci, Umberto, Giovanni Galati, Chiara Mazzarelli, et al.. (2010). Angiogenic Cytokines in Patients Undergoing Antiviral Treatment for Chronic Hepatitis C Virus Infection. Journal of Interferon & Cytokine Research. 31(2). 207–210. 7 indexed citations

19.

Iñarrairaegui, Mercedes, Antonio Martínez-Cuesta, Macarena Rodríguez‐Fraile, et al.. (2010). Analysis of Prognostic Factors After Yttrium-90 Radioembolization of Advanced Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 77(5). 1441–1448. 38 indexed citations

20.

Vespasiani‐Gentilucci, Umberto, Giuseppe Perrone, Giovanni Galati, et al.. (2006). Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus‐related chronic liver disease. Histopathology. 48(7). 822–830. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact